Jagannathan, N.S., Meena, N., Bhayankaram, K.P., & Prabakaran, S., 2019. Proteins encoded by Novel ORFs have increased disorder but can be biochemically regulated and harbour pathogenic mutations. bioRxiv.
Domingues, A.F. et al., 2018. Loss Of Kat2a Enhances Transcriptional Noise And Depletes Acute Myeloid Leukemia Stem-Like Cells. bioRxiv.
Jackson, F., Wayland, M.T. & Prabakaran, S., 2017. Identification And Prioritisation Of Variants In The Short Open-Reading Frame Regions Of The Human Genome. bioRxiv.
Slabodnick, M.M. et al., 2017. The Macronuclear Genome of Stentor coeruleus Reveals Tiny Introns in a Giant Cell. Current biology: CB, 27(4), pp.569–575
Lippens, G. et al., 2017. Post-translational Modifications of the Proteome: The Example of Tau in the Neuron and the Brain. In Joseph Loscalzo Albert-László Barabási Edwin K. Silverman, ed. Network Medicine: Complex Systems in Human Disease and Therapeutics. Cambridge, MA: Harvard University Press
Qi, H. et al., 2017. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein. Methods in molecular biology , 1523, pp.179–213.
Qi, H. et al., 2016. Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase. The Journal of biological chemistry, 291(14), pp.7742–7753.
Prabakaran, S., Gunawardena, J. & Sontag, E., 2014. Paradoxical results in perturbation-based signaling network reconstruction. Biophysical journal, 106(12), pp.2720–2728.
Prabakaran, S., Hemberg, M., et al., 2014. Quantitative profiling of peptides from RNAs classified as noncoding. Nature communications, 5, p.5429.
Prabakaran, S. et al., 2012. Post-translational modification: nature’s escape from genetic imprisonment and the basis for dynamic information encoding. Wiley interdisciplinary reviews. Systems biology and medicine, 4(6), pp.565–583.
Prabakaran, S. et al., 2011. Comparative analysis of Erk phosphorylation suggests a mixed strategy for measuring phospho-form distributions. Molecular systems biology, 7, p.482.
Schwarz, E. et al., 2008. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. Journal of proteome research, 7(10), pp.4266–4277.
Huang, J.T.-J. et al., 2008. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. Molecular psychiatry, 13(12), pp.1118–1128.
Prabakaran, S. et al., 2007. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. Journal of proteome research, 6(1), pp.141–149.
Prabakaran, S. et al., 2004. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular psychiatry, 9(7), pp.684–97, 643.
Swatton, J.E. et al., 2004. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Molecular psychiatry, 9(2), pp.128–143.